VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Vaccine Mechanisms
Vaximmutordb
Vaxism
Vaxar
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UMMS Logo

Vaxlert: Peer-reviewed Vaccine Publications in Current Month

From Dec 01, 2020 To Dec 04, 2020:


Bacillus anthracis (Anthrax)

  1. Chateau A, Van der Verren SE, Remaut H, Fioravanti A. The <i>Bacillus anthracis</i> Cell Envelope: Composition, Physiological Role, and Clinical Relevance Microorganisms 8(12) 2020 [PMID: 33255913]

Coronavirus

  1. Ramesh P, Veerappapillai S, Karuppasamy R. Gene expression profiling of corona virus microarray datasets to identify crucial targets in COVID-19 patients Gene reports 22:100980 2021 [PMID: 33263093]
  2. Srivastava M, Srivastava N, Mishra PK, Malhotra BD. Prospects of nanomaterials-enabled biosensors for COVID-19 detection The Science of the total environment 754:142363 2021 [PMID: 33254928]
  3. Szkaradkiewicz-Karpińska AK, Szkaradkiewicz A. Towards a more effective strategy for COVID-19 prevention (Review) Experimental and therapeutic medicine 21(1):33 2021 [PMID: 33262819]
  4. Garcia-Beltran WF, Miller TE, Kirkpatrick G, Nixon A, Astudillo MG, Yang D, Mahanta LM, Murali M, Dighe AS, Lennerz J, Thierauf J, Naranbhai V, Iafrate AJ. Remote fingerstick blood collection for SARS-CoV-2 antibody testing Archives of pathology & laboratory medicine 2020 [PMID: 33264390]
  5. Russell R, Pelka P, Mark BL. Frontrunners in the race to develop a SARS-CoV-2 vaccine Canadian journal of microbiology 2020 [PMID: 33264067]
  6. Hajek A, König HH. Social Isolation and Loneliness of Older Adults in Times of the COVID-19 Pandemic: Can Use of Online Social Media Sites and Video Chats Assist in Mitigating Social Isolation and Loneliness? Gerontology :1-3 2020 [PMID: 33264778]
  7. Nguyen HL, Thai NQ, Truong DT, Li MS. Remdesivir Strongly Binds to Both RNA-Dependent RNA Polymerase and Main Protease of SARS-CoV-2: Evidence from Molecular Simulations The journal of physical chemistry. B 2020 [PMID: 33264025]
  8. Poh KC, Tay VYJ, Lin SH, Chee HL, Suhitharan T. A review of COVID-19-related thrombosis and anticoagulation strategies specific to the Asian population Singapore medical journal 2020 [PMID: 33264831]
  9. Sharma R, Sardar S, Mohammad Arshad A, Ata F, Zara S, Munir W. A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2 The American journal of case reports 21:e927154 2020 [PMID: 33257644]
  10. Zimmermann P, Curtis N. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections Archives of disease in childhood 2020 [PMID: 33262177]
  11. Kwarteng A, Asiedu E, Sakyi SA, Asiedu SO. Targeting the SARS-CoV2 nucleocapsid protein for potential therapeutics using immuno-informatics and structure-based drug discovery techniques Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 132:110914 2020 [PMID: 33254432]
  12. Wang G, Yang ML, Duan ZL, Liu FL, Jin L, Long CB, Zhang M, Tang XP, Xu L, Li YC, Kamau PM, Yang L, Liu HQ, Xu JW, Chen JK, Zheng YT, Peng XZ, Lai R. Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models Cell research 2020 [PMID: 33262453]
  13. Caddy SL, Vaysburd M, Papa G, Wing M, O'Connell K, Stoycheva D, Foss S, Terje Andersen J, Oxenius A, James LC. Viral nucleoprotein antibodies activate TRIM21 and induce T cell immunity The EMBO journal :e106228 2020 [PMID: 33258165]
  14. Crowley JP, Bleakley A, Silk K, Young DG, Lambe JL. Uncertainty Management and Curve Flattening Behaviors in the Wake of COVID-19's First Wave Health communication :1-10 2020 [PMID: 33256466]
  15. Kistler CE, Jump RLP, Sloane PD, Zimmerman S. The Winter Respiratory Viral Season During the COVID-19 Pandemic Journal of the American Medical Directors Association 21(12):1741-1745 2020 [PMID: 33256954]
  16. Zhu W, Yang J, Lu S, Lan R, Jin D, Luo XL, Pu J, Wu S, Xu J. Beta- and Novel Delta-Coronaviruses Are Identified from Wild Animals in the Qinghai-Tibetan Plateau, China Virologica Sinica 2020 [PMID: 33259031]
  17. Hossain MK, Hassanzadeganroudsari M, Apostolopoulos V. Why METH users are at high risk of fatality due to COVID-19 infection? Expert review of vaccines 2020 [PMID: 33249941]
  18. Salpini R, Alkhatib M, Costa G, Piermatteo L, Ambrosio FA, Di Maio VC, Scutari R, Duca L, Berno G, Fabeni L, Alcaro S, Ceccherini-Silberstein F, Artese A, Svicher V. Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control The Journal of antimicrobial chemotherapy 2020 [PMID: 33254234]
  19. Maurya DK, Sharma D. Evaluation of traditional ayurvedic Kadha for prevention and management of the novel Coronavirus (SARS-CoV-2) using in silico approach Journal of biomolecular structure & dynamics :1-16 2020 [PMID: 33251972]
  20. Utamura M, Koizumi M, Kirikami S. Isolation Considered Epidemiological Model for the Prediction of COVID-19 Trend in Tokyo, Japan: Numerical Study JMIR public health and surveillance 2020 [PMID: 33259325]
  21. Chattopadhyay S, Hu CJ. Nanomedicinal delivery of stimulator of interferon genes agonists: recent advances in virus vaccination Nanomedicine (London, England) 2020 [PMID: 33252301]
  22. Chiuppesi F, Salazar MD, Contreras H, Nguyen VH, Martinez J, Park Y, Nguyen J, Kha M, Iniguez A, Zhou Q, Kaltcheva T, Levytskyy R, Ebelt ND, Kang TH, Wu X, Rogers TF, Manuel ER, Shostak Y, Diamond DJ, Wussow F. Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform Nature communications 11(1):6121 2020 [PMID: 33257686]
  23. Hörner C, Schürmann C, Auste A, Ebenig A, Muraleedharan S, Dinnon KH 3rd, Scholz T, Herrmann M, Schnierle BS, Baric RS, Mühlebach MD. A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine Proceedings of the National Academy of Sciences of the United States of America 2020 [PMID: 33257540]
  24. Behmard E, Soleymani B, Najafi A, Barzegari E. Immunoinformatic design of a COVID-19 subunit vaccine using entire structural immunogenic epitopes of SARS-CoV-2 Scientific reports 10(1):20864 2020 [PMID: 33257716]
  25. Jain N, Shankar U, Majee P, Kumar A. Scrutinizing the SARS-CoV-2 protein information for designing an effective vaccine encompassing both the T-cell and B-cell epitopes Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases :104648 2020 [PMID: 33264668]
  26. Mouchtouri VA, Agathagelidou E, Kofonikolas K, Rousou X, Dadouli K, Pinaka O, Agathocleous E, Anagnostopoulou L, Chatziligou C, Christoforidou EP, Chalntoupi T, Kalomoiris L, Kapoula C, Kokkinou V, Constantinides A, Konstantinou P, Kostara E, Kourentis L, Lantou A, Lempidakis G, Liasidi PN, Michalakis C, Panagiotou D, Panteliadou F, Papadoulis V, Papantoniou G, Psatha M, Ragias D, Ringa V, Syrakouli A, Skoutari A, Stergiadou S, Theodorou A, Tzika V, Lagiou A, Dardavesis T, Prezerakos P, Hadjichristodoulou C. Nationwide Survey in Greece about Knowledge, Risk Perceptions, and Preventive Behaviors for COVID-19 during the General Lockdown in April 2020 International journal of environmental research and public health 17(23) 2020 [PMID: 33260789]
  27. Terpos E, Politou M, Sergentanis TN, Mentis A, Rosati M, Stellas D, Bear J, Hu X, Felber BK, Pappa V, Pagoni M, Grouzi E, Labropoulou S, Charitaki I, Ntanasis-Stathopoulos I, Moschandreou D, Bouhla A, Saridakis S, Korompoki E, Giatra C, Bagratuni T, Pefanis A, Papageorgiou S, Spyridonidis A, Antoniadou A, Kotanidou A, Syrigos K, Stamoulis K, Panayiotakopoulos G, Tsiodras S, Alexopoulos L, Dimopoulos MA, Pavlakis GN. Anti-SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study Microorganisms 8(12) 2020 [PMID: 33260775]
  28. Mishra SK, Tripathi T. One Year Update on the COVID-19 Pandemic: Where Are We Now? Acta tropica :105778 2020 [PMID: 33253656]
  29. Rizk JG, Forthal DN, Kalantar-Zadeh K, Mehra MR, Lavie CJ, Rizk Y, Pfeiffer JP, Lewin JC. Expanded Access Programs, compassionate drug Use, and Emergency Use Authorizations during the COVID-19 pandemic Drug discovery today 2020 [PMID: 33253920]
  30. Mazzini L, Martinuzzi D, Hyseni I, Benincasa L, Molesti E, Casa E, Lapini G, Piu P, Trombetta CM, Marchi S, Razzano I, Manenti A, Montomoli E. Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples Journal of immunological methods :112937 2020 [PMID: 33253698]
  31. Tiwari P, Kaur H. The Flood of COVID-19 Publications: a Word of Caution SN comprehensive clinical medicine :1-3 2020 [PMID: 33263102]
  32. Oves M, Ravindran M, Rauf MA, Omaish Ansari M, Zahin M, Iyer AK, Ismail IMI, Khan MA, Palaniyar N. Comparing and Contrasting MERS, SARS-CoV, and SARS-CoV-2: Prevention, Transmission, Management, and Vaccine Development Pathogens (Basel, Switzerland) 9(12) 2020 [PMID: 33255989]
  33. Kraaijeveld SR. COVID-19: Against a Lockdown Approach Asian bioethics review :1-18 2020 [PMID: 33262838]
  34. Garry S, Abdelmagid N, Baxter L, Roberts N, le Polain de Waroux O, Ismail S, Ratnayake R, Favas C, Lewis E, Checchi F. Considerations for planning COVID-19 treatment services in humanitarian responses Conflict and health 14:80 2020 [PMID: 33250932]
  35. Augustin TL, Hajbabaie R, Harper MT, Rahman T. Novel Small-Molecule Scaffolds as Candidates against the SARS Coronavirus 2 Main Protease: A Fragment-Guided in Silico Approach Molecules (Basel, Switzerland) 25(23) 2020 [PMID: 33255326]
  36. Das C, Paul SS, Saha A, Singh T, Saha A, Im J, Biswas G. Silver-Based Nanomaterials as Therapeutic Agents Against Coronaviruses: A Review International journal of nanomedicine 15:9301-9315 2020 [PMID: 33262589]
  37. Zhou LP, Wang J, Xie RH, Pakhale S, Krewski D, Cameron DW, Wen SW. The Effects of Traditional Chinese Medicine as an Auxiliary Treatment for COVID-19: A Systematic Review and Meta-analysis Journal of alternative and complementary medicine (New York, N.Y.) 2020 [PMID: 33252246]
  38. Kim E. Repurposing COVID-19 Drive-Through Testing Centers for Mass Vaccination Journal of multidisciplinary healthcare 13:1665-1667 2020 [PMID: 33262601]
  39. Al-Mohaithef M, Padhi BK. Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey Journal of multidisciplinary healthcare 13:1657-1663 2020 [PMID: 33262600]
  40. Chan SW. Current and Future Direct-Acting Antivirals Against COVID-19 Frontiers in microbiology 11:587944 2020 [PMID: 33262747]
  41. Shetty R, Murugeswari P, Chakrabarty K, Jayadev C, Matalia H, Ghosh A, Das D. Stem cell therapy in coronavirus disease 2019: current evidence and future potential Cytotherapy 2020 [PMID: 33257213]
  42. Lee CH, Pinho MP, Buckley PR, Woodhouse IB, Ogg G, Simmons A, Napolitani G, Koohy H. Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains Frontiers in immunology 11:579480 2020 [PMID: 33250893]
  43. Richardson LJ, Bélanger JJ. COVID-19 Knowledge Test: An Assessment Tool for Health Educators During the COVID-19 Pandemic Frontiers in public health 8:580204 2020 [PMID: 33251174]
  44. Wijesundara DK, Avumegah MS, Lackenby J, Modhiran N, Isaacs A, Young PR, Watterson D, Chappell KJ. Rapid Response Subunit Vaccine Design in the Absence of Structural Information Frontiers in immunology 11:592370 2020 [PMID: 33250897]
  45. Kumar P, Malik YS, Ganesh B, Rahangdale S, Saurabh S, Natesan S, Srivastava A, Sharun K, Yatoo MI, Tiwari R, Singh RK, Dhama K. CRISPR-Cas System: An Approach With Potentials for COVID-19 Diagnosis and Therapeutics Frontiers in cellular and infection microbiology 10:576875 2020 [PMID: 33251158]
  46. Mandal M, Jana S, Khatua A, Kar TK. Modeling and control of COVID-19: A short-term forecasting in the context of India Chaos (Woodbury, N.Y.) 30(11):113119 2020 [PMID: 33261356]
  47. Bajiya VP, Bugalia S, Tripathi JP. Mathematical modeling of COVID-19: Impact of non-pharmaceutical interventions in India Chaos (Woodbury, N.Y.) 30(11):113143 2020 [PMID: 33261327]
  48. Rossi M, Piagnerelli M, Van Meerhaeghe A, Zouaoui Boudjeltia K. Heme oxygenase-1 (HO-1) cytoprotective pathway: A potential treatment strategy against coronavirus disease 2019 (COVID-19)-induced cytokine storm syndrome Medical hypotheses 144:110242 2020 [PMID: 33254548]
  49. Takahashi H. Role of latent tuberculosis infections in reduced COVID-19 mortality: Evidence from an instrumental variable method analysis Medical hypotheses 144:110214 2020 [PMID: 33254521]
  50. Kapoor N, Ghorai SM, Kushwaha PK, Shukla R, Aggarwal C, Bandichhor R. Plausible mechanisms explaining the role of cucurbitacins as potential therapeutic drugs against coronavirus 2019 Informatics in medicine unlocked 21:100484 2020 [PMID: 33251326]

Ebola virus

  1. Carroll C, Booth A, Campbell F, Relton C. Qualitative evidence synthesis of values and preferences to inform infant feeding in the context of non-HIV transmission risk PloS one 15(12):e0242669 2020 [PMID: 33259512]
  2. Tran PT, Asghar N, Höglund U, Larsson O, Haag L, Mirazimi A, Johansson M, Melik W. Development of a Multivalent Kunjin Virus Reporter Virus-Like Particle System Inducing Seroconversion for Ebola and West Nile Virus Proteins in Mice Microorganisms 8(12) 2020 [PMID: 33260425]
  3. Agnolon V, Kiseljak D, Wurm MJ, Wurm FM, Foissard C, Gallais F, Wehrle S, Muñoz-Fontela C, Bellanger L, Correia BE, Corradin G, Spertini F. Designs and Characterization of Subunit Ebola GP Vaccine Candidates: Implications for Immunogenicity Frontiers in immunology 11:586595 2020 [PMID: 33250896]

Escherichia coli

  1. Kwak C, Nguyen QT, Kim J, Kim TH, Poo H. Influenza chimeric protein (3M2e-3HA2-NP) adjuvanted with PGA/alum conferred cross-protection against heterologous influenza A viruses Journal of microbiology and biotechnology 2020 [PMID: 33263336]
  2. Talaat KR, Porter CK, Jaep KM, Duplessis CA, Gutierrez RL, Maciel M Jr, Adjoodani B, Feijoo B, Chakraborty S, Brubaker J, Trop SA, Riddle MS, Joseph SS, Bourgeois AL, Prouty MG. Refinement of the CS6-expressing enterotoxigenic Escherichia coli strain B7A human challenge model: A randomized trial PloS one 15(12):e0239888 2020 [PMID: 33264302]

Human immunodeficiency virus (acquired immunodeficiency syndrome)

  1. Krause PR, Fleming TR, Longini IM, Peto R, Beral V, Bhargava B, Cravioto A, Cramer J, Ellenberg SS, Figueroa JP, Halloran E, Henao-Restrepo AM, Ryan MJ, Levine MM, Nason M, Nohynek HM, Plotkin S, Rees H, Singh JA, Swaminathan S. Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them The New England journal of medicine 2020 [PMID: 33264543]
  2. Kwarteng A, Asiedu E, Sakyi SA, Asiedu SO. Targeting the SARS-CoV2 nucleocapsid protein for potential therapeutics using immuno-informatics and structure-based drug discovery techniques Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 132:110914 2020 [PMID: 33254432]
  3. Faini D, Munseri P, Bakari M, Sandström E, Faxelid E, Hanson C. "I did not plan to have a baby. This is the outcome of our work": a qualitative study exploring unintended pregnancy among female sex workers BMC women's health 20(1):267 2020 [PMID: 33261591]
  4. Rakshit S, Hingankar N, Alampalli SV, Adiga V, Sundararaj BK, Sahoo PN, Finak G, Uday Kumar J AJ, Dhar C, D'Souza G, Virkar RG, Ghate M, Thakar MR, Paranjape RS, De Rosa SC, Ottenhoff THM, Vyakarnam A. HIV Skews a Balanced Mtb-Specific Th17 Response in Latent Tuberculosis Subjects to a Pro-inflammatory Profile Independent of Viral Load Cell reports 33(9):108451 2020 [PMID: 33264614]
  5. Wang X, Ray R, Kratochvil S, Melzi E, Lin YC, Giguere S, Xu L, Warner J, Cheon D, Liguori A, Groschel B, Phelps N, Adachi Y, Tingle R, Wu L, Crotty S, Kirsch KH, Nair U, Schief WR, Batista FD. Multiplexed CRISPR/CAS9-mediated engineering of pre-clinical mouse models bearing native human B cell receptors The EMBO journal :e105926 2020 [PMID: 33258500]
  6. Kistler CE, Jump RLP, Sloane PD, Zimmerman S. The Winter Respiratory Viral Season During the COVID-19 Pandemic Journal of the American Medical Directors Association 21(12):1741-1745 2020 [PMID: 33256954]
  7. Carroll C, Booth A, Campbell F, Relton C. Qualitative evidence synthesis of values and preferences to inform infant feeding in the context of non-HIV transmission risk PloS one 15(12):e0242669 2020 [PMID: 33259512]
  8. Oduguwa E, Dongarwar D, Salihu HM. Trends in Premature Deaths among Women Living with HIV/AIDS and Cervical Cancer Southern medical journal 113(12):651-658 2020 [PMID: 33263137]
  9. Chattopadhyay S, Hu CJ. Nanomedicinal delivery of stimulator of interferon genes agonists: recent advances in virus vaccination Nanomedicine (London, England) 2020 [PMID: 33252301]
  10. Godot V, Tcherakian C, Gil L, Cervera-Marzal I, Li G, Cheng L, Ortonne N, Lelièvre JD, Pantaleo G, Fenwick C, Centlivre M, Mouquet H, Cardinaud S, Zurawski SM, Zurawski G, Milpied P, Su L, Lévy Y. TLR-9 agonist and CD40-targeting vaccination induces HIV-1 envelope-specific B cells with a diversified immunoglobulin repertoire in humanized mice PLoS pathogens 16(11):e1009025 2020 [PMID: 33253297]
  11. Olorunsaiye CZ, Brunner Huber LR, Laditka SB, Kulkarni SJ, Boyd S. Individual and community socioeconomic factors related to the quality of antenatal care: a multilevel analysis of West and Central Africa Women & health :1-12 2020 [PMID: 33256565]
  12. van Regenmortel MHV. What does it mean to develop an HIV vaccine by rational design? Archives of virology 2020 [PMID: 33251565]
  13. Sasso E, D'Alise AM, Zambrano N, Scarselli E, Folgori A, Nicosia A. New viral vectors for infectious diseases and cancer Seminars in immunology :101430 2020 [PMID: 33262065]
  14. Ben-Othman R, Cai B, Liu AC, Varankovich N, He D, Blimkie TM, Lee AH, Gill EE, Novotny M, Aevermann B, Drissler S, Shannon CP, McCann S, Marty K, Bjornson G, Edgar RD, Lin DTS, Gladish N, Maclsaac J, Amenyogbe N, Chan Q, Llibre A, Collin J, Landais E, Le K, Reiss SM, Koff WC, Havenar-Daughton C, Heran M, Sangha B, Walt D, Krajden M, Crotty S, Sok D, Briney B, Burton DR, Duffy D, Foster LJ, Mohn WW, Kobor MS, Tebbutt SJ, Brinkman RR, Scheuermann RH, Hancock REW, Kollmann TR, Sadarangani M. Systems Biology Methods Applied to Blood and Tissue for a Comprehensive Analysis of Immune Response to Hepatitis B Vaccine in Adults Frontiers in immunology 11:580373 2020 [PMID: 33250895]
  15. Kroon EDMB, Ananworanich J, Pagliuzza A, Rhodes A, Phanuphak N, Trautmann L, Mitchell JL, Chintanaphol M, Intasan J, Pinyakorn S, Benjapornpong K, Chang JJ, Colby DJ, Chomchey N, Fletcher JLK, Eubanks K, Yang H, Kapson J, Dantanarayana A, Tennakoon S, Gorelick RJ, Maldarelli F, Robb ML, Kim JH, Spudich S, Chomont N, Phanuphak P, Lewin SR, de Souza MS. A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection Journal of virus eradication 6(3):100004 2020 [PMID: 33251022]
  16. Posuwan N, Wanlapakorn N, Sintusek P, Wasitthankasem R, Poovorawan K, Vongpunsawad S, Poovorawan Y. Towards the elimination of viral hepatitis in Thailand by the year 2030 Journal of virus eradication 6(3):100003 2020 [PMID: 33251021]

Mycobacterium tuberculosis (tuberculosis)

  1. Rakshit S, Hingankar N, Alampalli SV, Adiga V, Sundararaj BK, Sahoo PN, Finak G, Uday Kumar J AJ, Dhar C, D'Souza G, Virkar RG, Ghate M, Thakar MR, Paranjape RS, De Rosa SC, Ottenhoff THM, Vyakarnam A. HIV Skews a Balanced Mtb-Specific Th17 Response in Latent Tuberculosis Subjects to a Pro-inflammatory Profile Independent of Viral Load Cell reports 33(9):108451 2020 [PMID: 33264614]
  2. Kim SY, Kim D, Kim S, Lee D, Mun SJ, Cho E, Son W, Jang K, Yang CS. Mycobacterium tuberculosis Rv2626c-derived peptide as a therapeutic agent for sepsis EMBO molecular medicine :e12497 2020 [PMID: 33258196]
  3. Safar HA, Mustafa AS, McHugh TD. COVID-19 vaccine development: What lessons can we learn from TB? Annals of clinical microbiology and antimicrobials 19(1):56 2020 [PMID: 33256750]
  4. Kadir NA, Acosta A, Sarmiento ME, Norazmi MN. Immunomodulatory Effects of Recombinant <i>Mycobacterium smegmatis</i> Expressing Antigen-85B Epitopes in Infected J774A.1 Murine Macrophages Pathogens (Basel, Switzerland) 9(12) 2020 [PMID: 33260418]
  5. Sfakianos JP, Salome B, Daza J, Farkas A, Bhardwaj N, Horowitz A. Bacillus Calmette-Guerin (BCG): Its fight against pathogens and cancer Urologic oncology 2020 [PMID: 33262028]
  6. Machlaurin A, Dolk FCK, Setiawan D, van der Werf TS, Postma MJ. Cost-Effectiveness Analysis of BCG Vaccination against Tuberculosis in Indonesia: A Model-Based Study Vaccines 8(4) 2020 [PMID: 33256143]
  7. Aftabi Y, Rafei S, Zarredar H, Amiri-Sadeghan A, Akbari-Shahpar M, Khoshkam Z, Seyedrezazadeh E, Khalili M, Mehrnejad F, Fereidouni S, Lawrence BP. Refinement of coding SNPs in the human aryl hydrocarbon receptor gene using ISNPranker: An integrative-SNP ranking web-tool Computational biology and chemistry 90:107416 2020 [PMID: 33264727]
  8. Ivanyi J. Tuberculosis vaccination needs to avoid 'decoy' immune reactions Tuberculosis (Edinburgh, Scotland) 126:102021 2020 [PMID: 33254012]
  9. Hajjo R, Sabbah DA, Bardaweel SK. Chemocentric Informatics Analysis: Dexamethasone <i>Versus</i> Combination Therapy for COVID-19 ACS omega 5(46):29765-29779 2020 [PMID: 33251412]
  10. Zhang S, Liu S, Liu N, Li C, Wang H, Shi L, Zhang X, Bao L, Yao Y, Shi L. Polymorphisms in <i>ERAP1</i> and <i>ERAP2</i> Genes Are Associated With Tuberculosis in the Han Chinese Frontiers in genetics 11:566190 2020 [PMID: 33250919]
  11. Ben-Othman R, Cai B, Liu AC, Varankovich N, He D, Blimkie TM, Lee AH, Gill EE, Novotny M, Aevermann B, Drissler S, Shannon CP, McCann S, Marty K, Bjornson G, Edgar RD, Lin DTS, Gladish N, Maclsaac J, Amenyogbe N, Chan Q, Llibre A, Collin J, Landais E, Le K, Reiss SM, Koff WC, Havenar-Daughton C, Heran M, Sangha B, Walt D, Krajden M, Crotty S, Sok D, Briney B, Burton DR, Duffy D, Foster LJ, Mohn WW, Kobor MS, Tebbutt SJ, Brinkman RR, Scheuermann RH, Hancock REW, Kollmann TR, Sadarangani M. Systems Biology Methods Applied to Blood and Tissue for a Comprehensive Analysis of Immune Response to Hepatitis B Vaccine in Adults Frontiers in immunology 11:580373 2020 [PMID: 33250895]
  12. Takahashi H. Role of latent tuberculosis infections in reduced COVID-19 mortality: Evidence from an instrumental variable method analysis Medical hypotheses 144:110214 2020 [PMID: 33254521]
  13. Posuwan N, Wanlapakorn N, Sintusek P, Wasitthankasem R, Poovorawan K, Vongpunsawad S, Poovorawan Y. Towards the elimination of viral hepatitis in Thailand by the year 2030 Journal of virus eradication 6(3):100003 2020 [PMID: 33251021]

Plasmodium falciparum (Malaria)

  1. Kucharska I, Thai E, Srivastava A, Rubinstein JL, Pomès R, Julien JP. Structural ordering of the <i>Plasmodium berghei</i> circumsporozoite protein repeats by inhibitory antibody 3D11 eLife 9 2020 [PMID: 33253113]
  2. Hogan AB, Winskill P, Ghani AC. Estimated impact of RTS,S/AS01 malaria vaccine allocation strategies in sub-Saharan Africa: A modelling study PLoS medicine 17(11):e1003377 2020 [PMID: 33253211]
  3. Olorunsaiye CZ, Brunner Huber LR, Laditka SB, Kulkarni SJ, Boyd S. Individual and community socioeconomic factors related to the quality of antenatal care: a multilevel analysis of West and Central Africa Women & health :1-12 2020 [PMID: 33256565]
  4. Sasso E, D'Alise AM, Zambrano N, Scarselli E, Folgori A, Nicosia A. New viral vectors for infectious diseases and cancer Seminars in immunology :101430 2020 [PMID: 33262065]
  5. Posuwan N, Wanlapakorn N, Sintusek P, Wasitthankasem R, Poovorawan K, Vongpunsawad S, Poovorawan Y. Towards the elimination of viral hepatitis in Thailand by the year 2030 Journal of virus eradication 6(3):100003 2020 [PMID: 33251021]

Salmonella

  1. Saha S, Sayeed KMI, Saha S, Islam MS, Rahaman A, Islam M, Rahman H, Das R, Hasan MM, Uddin MJ, Tanmoy AM, Ahmed ASMNU, Luby SP, Andrews JR, Garrett DO, Saha SK. Hospitalization of Pediatric Enteric Fever Cases, Dhaka, Bangladesh, 2017-2019: Incidence and Risk Factors Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 71(Supplement_3):S196-S204 2020 [PMID: 33258942]
  2. Aiemjoy K, Tamrakar D, Saha S, Naga SR, Yu AT, Longley A, Date K, Hemlock C, Qamar FN, Saha SK, Luby SP, Garrett DO, Andrews JR, Bogoch II. Diagnostic Value of Clinical Features to Distinguish Enteric Fever From Other Febrile Illnesses in Bangladesh, Nepal, and Pakistan Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 71(Supplement_3):S257-S265 2020 [PMID: 33258936]
  3. Qamar FN, Yousafzai MT, Dehraj IF, Shakoor S, Irfan S, Hotwani A, Hunzai MJ, Thobani RS, Rahman N, Mehmood J, Hemlock C, Memon AM, Andrews JR, Luby SP, Garrett DO, Longley AT, Date K, Saha SK. Antimicrobial Resistance in Typhoidal Salmonella: Surveillance for Enteric Fever in Asia Project, 2016-2019 Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 71(Supplement_3):S276-S284 2020 [PMID: 33258934]
  4. Tamrakar D, Vaidya K, Yu AT, Aiemjoy K, Naga SR, Cao Y, Bern C, Shrestha R, Karmacharya BM, Pradhan S, Qamar FN, Saha S, Date K, Longley AT, Hemlock C, Luby S, Garrett DO, Bogoch II, Andrews JR. Spatial Heterogeneity of Enteric Fever in 2 Diverse Communities in Nepal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 71(Supplement_3):S205-S213 2020 [PMID: 33258932]
  5. Yousafzai MT, Irfan S, Thobani RS, Kazi AM, Hotwani A, Memon AM, Iqbal K, Qazi SH, Saddal NS, Rahman N, Dehraj IF, Hunzai MJ, Mehmood J, Garrett DO, Saha SK, Andrews JR, Luby SP, Qamar FN. Burden of Culture Confirmed Enteric Fever Cases in Karachi, Pakistan: Surveillance For Enteric Fever in Asia Project (SEAP), 2016-2019 Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 71(Supplement_3):S214-S221 2020 [PMID: 33258931]
  6. Carter AS, Luby SP, Garrett DO. Introducing Typhoid Conjugate Vaccine in South Asia: Lessons From the Surveillance for Enteric Fever in Asia Project Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 71(Supplement_3):S191-S195 2020 [PMID: 33258930]
  7. Qazi SH, Yousafzai MT, Saddal NS, Dehraj IF, Thobani RS, Akhtar A, Syed JR, Kazi AM, Hotwani A, Rahman N, Mehmood J, Andrews JR, Luby SP, Garrett DO, Qamar FN. Burden of Ileal Perforations Among Surgical Patients Admitted in Tertiary Care Hospitals of Three Asian countries: Surveillance of Enteric Fever in Asia Project (SEAP), September 2016-September 2019 Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 71(Supplement_3):S232-S238 2020 [PMID: 33258928]
  8. Wang Z, Mi J, Wang Y, Wang T, Qi X, Li K, Pan Q, Gao Y, Gao L, Liu C, Zhang Y, Wang X, Cui H. Recombinant Lactococcus Expressing a Novel Variant of Infectious Bursal Disease Virus VP2 Protein Can Induce Unique Specific Neutralizing Antibodies in Chickens and Provide Complete Protection Viruses 12(12) 2020 [PMID: 33255742]

Variola major (Smallpox)

  1. Orsini D, Martini M. From inoculation to vaccination: the fight against smallpox in Siena in the 18th and 19th centuries Le infezioni in medicina 28(4):634-641 2020 [PMID: 33257641]
  2. Ellis H. James Phipps, first to be vaccinated against smallpox by Edward Jenner Journal of perioperative practice :1750458920950165 2020 [PMID: 33251953]
  3. Sasso E, D'Alise AM, Zambrano N, Scarselli E, Folgori A, Nicosia A. New viral vectors for infectious diseases and cancer Seminars in immunology :101430 2020 [PMID: 33262065]

Click HERE to see the publications in the last month.